Acadian Asset Management LLC Protagonist Therapeutics, Inc Transaction History

Acadian Asset Management LLC

$34.5 Billion
Q4 2024

A detailed history of Acadian Asset Management LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 5,889 shares of PTGX stock, worth $262,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,889

Previous 2,387 146.71%

Holding current value

$262,590

Previous $106,000 113.21%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$38.51 - $48.43 $134,862 - $169,601	3,502 Added 146.71%	5,889 $226,000
Q3 2024 Nov 12, 2024	BUY	$33.72 - $47.33 $80,489 - $112,976	2,387 New	2,387 $106,000
Q4 2022 Feb 14, 2023	SELL	$7.36 - $11.17 $942,087 - $1.43 Million	-128,001 Reduced 93.3%	9,199 $100,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $1.08 Million - $1.61 Million	137,200 New	137,200 $1.16 Million
Q1 2021 May 11, 2021	SELL	$19.02 - $31.15 $291,937 - $478,121	-15,349 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$18.49 - $25.13 $283,803 - $385,720	15,349 New	15,349 $309,000
Q4 2019 Feb 06, 2020	SELL	$4.69 - $13.45 $736,147 - $2.11 Million	-156,961 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$9.41 - $16.56 $1.48 Million - $2.6 Million	156,961 New	156,961 $1.89 Million
Q2 2019 Aug 08, 2019	SELL	$8.98 - $12.96 $2.18 Million - $3.15 Million	-242,862 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$6.5 - $13.77 $86,827 - $183,939	-13,358 Reduced 5.21%	242,862 $3.05 Million
Q4 2018 Feb 07, 2019	BUY	$6.3 - $10.44 $41,050 - $68,027	6,516 Added 2.61%	256,220 $1.73 Million
Q3 2018 Oct 30, 2018	BUY	$6.82 - $11.26 $108,260 - $178,741	15,874 Added 6.79%	249,704 $2.57 Million
Q2 2018 Jul 24, 2018	BUY	$5.99 - $9.1 $1.05 Million - $1.6 Million	175,849 Added 303.29%	233,830 $1.57 Million
Q1 2018 Apr 12, 2018	BUY	$8.46 - $23.08 $410,496 - $1.12 Million	48,522 Added 512.97%	57,981 $498,000
Q4 2017 Jan 18, 2018	BUY	$14.47 - $20.8 $136,871 - $196,747	9,459	9,459 $197,000

Others Institutions Holding PTGX

# of Institutions

293

Shares Held

60.7M

Call Options Held

1.01M

Put Options Held

555K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.19B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Protagonist Therapeutics, Inc Transaction History